Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| FMC CORPFMC · Entity 4704 | Director | July 16, 2026 | July 17, 2026 |
| QUAKER CHEMICAL CORPKWR · Entity 4278 | Director | February 10, 2026 | February 12, 2026 |
| ROGERS CORPROG · Entity 4438 | Director | May 09, 2019 | May 13, 2019 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
FMC CORP
Report date July 16, 2026 · Filed July 17, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 28,820.191 |
Reported balance
After 2026-07-16 transaction · row 1
1 source rowRow 1 · 2026-07-16 · Grant · Acquired 11 · Balance 28,820.191 F1: These shares were issued pursuant to dividend equivalent rights in connection with vested restricted stock units held by the reporting person. |
Filing footnotes · ownership attribution and instrument terms
F1: These shares were issued pursuant to dividend equivalent rights in connection with vested restricted stock units held by the reporting person.
QUAKER CHEMICAL CORP
Report date February 10, 2026 · Filed February 12, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 78,010 |
Ending reported balance
After 2026-02-10 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-02-10 · Exercise / conversion · Acquired 8,212 · Balance 84,886 Row 2 · 2026-02-10 · Tax withholding · Disposed 6,876 · Balance 78,010 |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $136.64 · Expires 2027-03-30 | Direct | 0 |
Reported balance
After 2026-02-10 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-02-10 · Exercise / conversion · Disposed 8,212 · Balance 0 F1: The options for this grant vested in three annual installments: 8,213 shares on March 30, 2021; 8,213 shares on March 30, 2022; and 8,212 shares on March 30, 2023. |
Filing footnotes · ownership attribution and instrument terms
F1: The options for this grant vested in three annual installments: 8,213 shares on March 30, 2021; 8,213 shares on March 30, 2022; and 8,212 shares on March 30, 2023.
ROGERS CORP
Report date May 09, 2019 · Filed May 13, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Capital (Common) StockSEC Table I · non-derivative | Direct | 17,350 |
Reported balance
After 2019-05-09 transaction · row 1
1 source rowRow 1 · 2019-05-09 · Grant · Acquired 850 · Balance 17,350 F1: Represents shares of Rogers Corporation Capital (Common) Stock receivable pursuant to the May 9, 2019 award of deferred stock units. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares of Rogers Corporation Capital (Common) Stock receivable pursuant to the May 9, 2019 award of deferred stock units.
Past disclosures · reporting ended (2)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Arcadium Lithium plc
Report date March 06, 2025 · Filed March 06, 2025
Section 16 reporting ended · disclosed 2025-03-06. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary SharesSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2025-03-06 transaction · row 1
Sequence does not reconcile; account continuity is unresolved.
1 source rowRow 1 · 2025-03-06 · Disposition to issuer · Disposed 92,061 · Balance 0 F1: Represents shares of common stock of Aracdium Lithium plc ("Arcadium") disposed of pursuant to the Transaction Agreement, dated October 9, 2024, by and among Arcadium, Rio Tinto Western Holdings Limited ("Parent") and Rio Tinto BM Subsidiary Limited ("Buyers") (the "Transaction Agreement"). Pursuant to the Transaction Agreement, at the effective time of the transaction contemplated thereby (the "Effective Time"), each share of Arcadium common stock held by the reporting person was converted automatically into the right to receive $5.85 per share in cash (the "Consideration"). |
| Ordinary SharesSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2025-03-06 transaction · row 2
Sequence does not reconcile; account continuity is unresolved.
1 source rowRow 2 · 2025-03-06 · Disposition to issuer · Disposed 40,786 · Balance 0 F2: Pursuant to the Transaction Agreement, at the Effective Time, each award of Arcadium restricted stock units held by the reporting person was canceled in exchange for the right to receive the Consideration in respect of each share of Arcadium common stock subject to such restricted stock unit award as of immediately prior to the Effective Time. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares of common stock of Aracdium Lithium plc ("Arcadium") disposed of pursuant to the Transaction Agreement, dated October 9, 2024, by and among Arcadium, Rio Tinto Western Holdings Limited ("Parent") and Rio Tinto BM Subsidiary Limited ("Buyers") (the "Transaction Agreement"). Pursuant to the Transaction Agreement, at the effective time of the transaction contemplated thereby (the "Effective Time"), each share of Arcadium common stock held by the reporting person was converted automatically into the right to receive $5.85 per share in cash (the "Consideration").
F2: Pursuant to the Transaction Agreement, at the Effective Time, each award of Arcadium restricted stock units held by the reporting person was canceled in exchange for the right to receive the Consideration in respect of each share of Arcadium common stock subject to such restricted stock unit award as of immediately prior to the Effective Time.
Livent Corp.
Report date January 04, 2024 · Filed January 08, 2024
Section 16 reporting ended · disclosed 2024-01-08. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2024-01-04 transaction · row 1
Sequence does not reconcile; account continuity is unresolved.
1 source rowRow 1 · 2024-01-04 · Disposition to issuer · Disposed 34,475 · Balance 0 F1: Represents the conversion of each share of common stock of the Livent Corporation ("Livent"), par value $0.001 per share ("Livent Common Stock"), held by the reporting person as of January 4, 2024, into the right to receive a number of validly issued, fully paid and non-assessable ordinary shares of Arcadium Lithium plc ("Arcadium"), par value $1.00 each ("Arcadium Shares") equal to the Merger Exchange Ratio (as defined in the Transaction Agreement, dated as of May 10, 2023, by and between Livent, Allkem Limited ("Allkem"), Lightning-A Merger Sub, Inc. and Arcadium, providing for a combination of Livent and Allkem in a merger of equals transaction (the "Transaction Agreement")). |
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2024-01-04 transaction · row 2
Sequence does not reconcile; account continuity is unresolved.
1 source rowRow 2 · 2024-01-04 · Disposition to issuer · Disposed 32,875 · Balance 0 F2: Represents the cancellation and conversion of restricted stock units ("Livent RSUs") with respect to shares of Livent Common Stock, held by the reporting person as of January 4, 2024, into an amount of cash equal to (i) the number of shares of Livent Common Stock subject to such Livent RSUs immediately prior to the Effective Time of the merger (as defined in the Transaction Agreement), multiplied by (ii) the higher of (A) the first available closing price of the Merger Consideration (as defined in the Transaction Agreement) and (B) the closing price per share of Livent Common Stock as reported in the New York Stock Exchange, on the last trading day preceding the Closing Date of the merger (as defined in the Transaction Agreement). |
Filing footnotes · ownership attribution and instrument terms
F1: Represents the conversion of each share of common stock of the Livent Corporation ("Livent"), par value $0.001 per share ("Livent Common Stock"), held by the reporting person as of January 4, 2024, into the right to receive a number of validly issued, fully paid and non-assessable ordinary shares of Arcadium Lithium plc ("Arcadium"), par value $1.00 each ("Arcadium Shares") equal to the Merger Exchange Ratio (as defined in the Transaction Agreement, dated as of May 10, 2023, by and between Livent, Allkem Limited ("Allkem"), Lightning-A Merger Sub, Inc. and Arcadium, providing for a combination of Livent and Allkem in a merger of equals transaction (the "Transaction Agreement")).
F2: Represents the cancellation and conversion of restricted stock units ("Livent RSUs") with respect to shares of Livent Common Stock, held by the reporting person as of January 4, 2024, into an amount of cash equal to (i) the number of shares of Livent Common Stock subject to such Livent RSUs immediately prior to the Effective Time of the merger (as defined in the Transaction Agreement), multiplied by (ii) the higher of (A) the first available closing price of the Merger Consideration (as defined in the Transaction Agreement) and (B) the closing price per share of Livent Common Stock as reported in the New York Stock Exchange, on the last trading day preceding the Closing Date of the merger (as defined in the Transaction Agreement).
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 16, 2026 Filed Jul 17, 2026 20:18 UTC | FMC CORP FMC · Entity 4704 | GrantCommon Stock | 11 | $0.00 | $0.00 |
DisclosureSEC source: 0000037785-26-000131 · form4.xml · nonDerivative · entry 1 BARRY MICHAEL F · CIK 0001238141 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,820.191 F1 · shares: These shares were issued pursuant to dividend equivalent rights in connection with vested restricted stock units held by the reporting person. Read SEC document |
| April 28, 2026 Filed Apr 30, 2026 20:11 UTC | FMC CORP FMC · Entity 4704 | GrantCommon Stock | 9,175 | $0.00 | $0.00 |
DisclosureSEC source: 0000037785-26-000098 · form4.xml · nonDerivative · entry 1 BARRY MICHAEL F · CIK 0001238141 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,809.191 Read SEC document |
| March 04, 2026 Filed Mar 5, 2026 17:11 UTC | FMC CORP FMC · Entity 4704 | PurchaseCommon Stock | 18,072.191 | $13.83 | $249,938.40 |
DisclosureSEC source: 0000037785-26-000045 · form4.xml · nonDerivative · entry 1 BARRY MICHAEL F · CIK 0001238141 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,634.191 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $13.77 to $13.86, inclusive. The reporting person undertakes to provide FMC Corporation, any security holder of FMC Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) of this Form 4. Read SEC document |
| February 27, 2026 Filed Mar 3, 2026 23:37 UTC | FMC CORP FMC · Entity 4704 | GrantCommon Stock | 1,562 | $0.00 | $0.00 |
DisclosureSEC source: 0000950103-26-003176 · dp242623_4-barry.xml · nonDerivative · entry 1 BARRY MICHAEL F · CIK 0001238141 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,562 Read SEC document |
| February 10, 2026 Filed Feb 12, 2026 21:25 UTC | QUAKER CHEMICAL CORP KWR · Entity 4278 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 8,212 | $0.00 Strike: $136.64 | $0.00 |
DisclosureSEC source: 0001238141-26-000003 · wk-form4_1770931518.xml · derivative · entry 3 BARRY MICHAEL F · CIK 0001238141 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,212 shares Expires 2027-03-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The options for this grant vested in three annual installments: 8,213 shares on March 30, 2021; 8,213 shares on March 30, 2022; and 8,212 shares on March 30, 2023. Read SEC document |
| February 10, 2026 Filed Feb 12, 2026 21:25 UTC | QUAKER CHEMICAL CORP KWR · Entity 4278 | Tax withholdingCommon Stock | 6,876 | $176.06 | $1,210,588.56 |
DisclosureSEC source: 0001238141-26-000003 · wk-form4_1770931518.xml · nonDerivative · entry 2 BARRY MICHAEL F · CIK 0001238141 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 78,010 Read SEC document |
| February 10, 2026 Filed Feb 12, 2026 21:25 UTC | QUAKER CHEMICAL CORP KWR · Entity 4278 | Exercise / conversionCommon Stock | 8,212 | $136.64 | $1,122,087.68 |
DisclosureSEC source: 0001238141-26-000003 · wk-form4_1770931518.xml · nonDerivative · entry 1 BARRY MICHAEL F · CIK 0001238141 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 84,886 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 01, 2025 Filed Jun 3, 2025 20:28 UTC | QUAKER CHEMICAL CORP KWR · Entity 4278 | GrantRestricted Stock Units · Derivative | 1,198 | $0.00 | $0.00 |
DisclosureSEC source: 0000081362-25-000086 · wk-form4_1748982500.xml · derivative · entry 5 BARRY MICHAEL F · CIK 0001238141 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,198 Underlying: Common Stock · 1,198 shares Expires not disclosed F4 · derivative.exercise_price: Time-based restricted stock units granted under the Company's Long-Term Performance Incentive Plan to Quaker Houghton's non-executive directors as part of their 2025 compensation. Each restricted stock unit represents a contingent right to receive one share of KWR common stock. F5 · shares: The restricted stock units vest 100% on May 31, 2026. Dividend equivalent rights accrue with respect to these restricted stock units when and as dividends are paid on KWR's common stock. F5 · derivative.exercise_date: The restricted stock units vest 100% on May 31, 2026. Dividend equivalent rights accrue with respect to these restricted stock units when and as dividends are paid on KWR's common stock. F5 · derivative.expiration_date: The restricted stock units vest 100% on May 31, 2026. Dividend equivalent rights accrue with respect to these restricted stock units when and as dividends are paid on KWR's common stock. Read SEC document |
| May 31, 2025 Filed Jun 3, 2025 20:28 UTC | QUAKER CHEMICAL CORP KWR · Entity 4278 | Exercise / conversionDividend Equivalent Rights · Derivative | 9 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000081362-25-000086 · wk-form4_1748982500.xml · derivative · entry 4 BARRY MICHAEL F · CIK 0001238141 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 9 shares Expires 2025-05-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Settlement of dividend equivalent rights in connection with vesting of restricted stock unit. The rights accrued when and as dividends were paid on KWR common stock. Each dividend equivalent right was the economic equivalent of one share of KWR common stock. F2 · price: Settlement of dividend equivalent rights in connection with vesting of restricted stock unit. The rights accrued when and as dividends were paid on KWR common stock. Each dividend equivalent right was the economic equivalent of one share of KWR common stock. F2 · derivative.exercise_date: Settlement of dividend equivalent rights in connection with vesting of restricted stock unit. The rights accrued when and as dividends were paid on KWR common stock. Each dividend equivalent right was the economic equivalent of one share of KWR common stock. Read SEC document |
| May 31, 2025 Filed Jun 3, 2025 20:28 UTC | QUAKER CHEMICAL CORP KWR · Entity 4278 | Exercise / conversionRestricted Stock Units · Derivative | 716 | $0.00 | $0.00 |
DisclosureSEC source: 0000081362-25-000086 · wk-form4_1748982500.xml · derivative · entry 3 BARRY MICHAEL F · CIK 0001238141 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 716 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F3 · derivative.exercise_date: On June 1, 2024, the reporting person was granted time-based restricted stock units that vested 100% on May 31, 2025. F3 · derivative.expiration_date: On June 1, 2024, the reporting person was granted time-based restricted stock units that vested 100% on May 31, 2025. Read SEC document |
| May 31, 2025 Filed Jun 3, 2025 20:28 UTC | QUAKER CHEMICAL CORP KWR · Entity 4278 | Exercise / conversionCommon Stock | 9 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000081362-25-000086 · wk-form4_1748982500.xml · nonDerivative · entry 2 BARRY MICHAEL F · CIK 0001238141 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 76,674 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Settlement of dividend equivalent rights in connection with vesting of restricted stock unit. The rights accrued when and as dividends were paid on KWR common stock. Each dividend equivalent right was the economic equivalent of one share of KWR common stock. Read SEC document |
| May 31, 2025 Filed Jun 3, 2025 20:28 UTC | QUAKER CHEMICAL CORP KWR · Entity 4278 | Exercise / conversionCommon Stock | 716 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000081362-25-000086 · wk-form4_1748982500.xml · nonDerivative · entry 1 BARRY MICHAEL F · CIK 0001238141 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 76,665 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| March 06, 2025 Filed Mar 6, 2025 23:26 UTC | Arcadium Lithium plc ALTM · Entity 82280 | Disposition to issuerOrdinary Shares | 40,786 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950103-25-003123 · dp225599_4-barry.xml · nonDerivative · entry 2 BARRY MICHAEL F · CIK 0001238141 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F2 · price: Pursuant to the Transaction Agreement, at the Effective Time, each award of Arcadium restricted stock units held by the reporting person was canceled in exchange for the right to receive the Consideration in respect of each share of Arcadium common stock subject to such restricted stock unit award as of immediately prior to the Effective Time. Read SEC document |
| March 06, 2025 Filed Mar 6, 2025 23:26 UTC | Arcadium Lithium plc ALTM · Entity 82280 | Disposition to issuerOrdinary Shares | 92,061 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950103-25-003123 · dp225599_4-barry.xml · nonDerivative · entry 1 BARRY MICHAEL F · CIK 0001238141 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · price: Represents shares of common stock of Aracdium Lithium plc ("Arcadium") disposed of pursuant to the Transaction Agreement, dated October 9, 2024, by and among Arcadium, Rio Tinto Western Holdings Limited ("Parent") and Rio Tinto BM Subsidiary Limited ("Buyers") (the "Transaction Agreement"). Pursuant to the Transaction Agreement, at the effective time of the transaction contemplated thereby (the "Effective Time"), each share of Arcadium common stock held by the reporting person was converted automatically into the right to receive $5.85 per share in cash (the "Consideration"). Read SEC document |
| July 26, 2024 Filed Jul 26, 2024 23:39 UTC | Arcadium Lithium plc ALTM · Entity 82280 | GrantOrdinary Shares | 40,786 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950103-24-010930 · dp215393_4-barry.xml · nonDerivative · entry 2 BARRY MICHAEL F · CIK 0001238141 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 132,847 F2 · shares: Reflects the grant of RSUs with respect to ordinary shares of the Issuer under the Issuer's Omnibus Incentive Plan (the "Plan"). The RSUs are scheduled to vest in full on the earliest of (i) the first anniversary of the date of grant, (ii) the date of the annual shareholders' meeting that next follows the grant date, or (iii) a change in control, subject to the terms of the Plan and the applicable award agreement issued thereunder. F2 · price: Reflects the grant of RSUs with respect to ordinary shares of the Issuer under the Issuer's Omnibus Incentive Plan (the "Plan"). The RSUs are scheduled to vest in full on the earliest of (i) the first anniversary of the date of grant, (ii) the date of the annual shareholders' meeting that next follows the grant date, or (iii) a change in control, subject to the terms of the Plan and the applicable award agreement issued thereunder. Read SEC document |
| July 24, 2024 Filed Jul 26, 2024 23:39 UTC | Arcadium Lithium plc ALTM · Entity 82280 | Tax withholdingOrdinary Shares | 5,683 | $3.45 | $19,606.35 |
DisclosureSEC source: 0000950103-24-010930 · dp215393_4-barry.xml · nonDerivative · entry 1 BARRY MICHAEL F · CIK 0001238141 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 92,061 F1 · shares: Represents shares withheld by the Issuer to cover tax obligations from the settlement of vested restricted stock units (RSUs). Read SEC document |
| June 01, 2024 Filed Jun 4, 2024 20:12 UTC | QUAKER CHEMICAL CORP KWR · Entity 4278 | GrantRestricted Stock Units · Derivative | 716 | $0.00 | $0.00 |
DisclosureSEC source: 0000081362-24-000075 · wk-form4_1717531958.xml · derivative · entry 2 BARRY MICHAEL F · CIK 0001238141 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 716 Underlying: Common Stock · 716 shares Expires not disclosed F1 · derivative.exercise_price: Time-based restricted stock units granted under the Company's Long-Term Performance Incentive Plan to Quaker Houghton's non-executive directors as part of their 2024 compensation. Each restricted stock unit represents a contingent right to receive one share of KWR common stock. F2 · shares: The restricted stock units vest 100% on May 31, 2025. Dividend equivalent rights accrue with respect to these restricted stock units when and as dividends are paid to KWR's common stock. F2 · derivative.exercise_date: The restricted stock units vest 100% on May 31, 2025. Dividend equivalent rights accrue with respect to these restricted stock units when and as dividends are paid to KWR's common stock. F2 · derivative.expiration_date: The restricted stock units vest 100% on May 31, 2025. Dividend equivalent rights accrue with respect to these restricted stock units when and as dividends are paid to KWR's common stock. Read SEC document |
| March 15, 2024 Filed Mar 19, 2024 20:30 UTC | QUAKER CHEMICAL CORP KWR · Entity 4278 | Tax withholdingCommon Stock | 849 | $200.16 | $169,935.84 |
DisclosureSEC source: 0000081362-24-000026 · wk-form4_1710880194.xml · nonDerivative · entry 1 BARRY MICHAEL F · CIK 0001238141 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 75,949 F1 · shares: Shares surrendered by reporting person to satisfy withholding tax obligation upon vesting of restricted stock granted on March 15, 2021 under the Company's Long-Term Performance Incentve Plan. Read SEC document |
| March 07, 2024 Filed Mar 11, 2024 21:12 UTC | Arcadium Lithium plc ALTM · Entity 82280 | GrantOrdinary Shares | 14,798 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950103-24-003657 · dp208208_4-barry.xml · nonDerivative · entry 1 BARRY MICHAEL F · CIK 0001238141 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 97,744 F1 · shares: Reflects the grant of restricted stock units (RSUs) with respect to ordinary shares of the Issuer under the Issuer's Omnibus Incentive Plan (the "Plan"). The RSUs are scheduled to vest in full on the earliest of (i) the first anniversary of the date of grant, (ii) the date of the annual shareholders' meeting that next follows the grant date, or (iii) a change in control, subject to the terms of the Plan and the applicable award agreement issued thereunder. F1 · price: Reflects the grant of restricted stock units (RSUs) with respect to ordinary shares of the Issuer under the Issuer's Omnibus Incentive Plan (the "Plan"). The RSUs are scheduled to vest in full on the earliest of (i) the first anniversary of the date of grant, (ii) the date of the annual shareholders' meeting that next follows the grant date, or (iii) a change in control, subject to the terms of the Plan and the applicable award agreement issued thereunder. Read SEC document |
| January 04, 2024 Filed Jan 8, 2024 21:14 UTC | Arcadium Lithium plc ALTM · Entity 82280 | GrantOrdinary Shares | 82,946 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950103-24-000425 · dp204968_4-barry.xml · nonDerivative · entry 1 BARRY MICHAEL F · CIK 0001238141 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 82,946 F1 · shares: Represents the conversion of common stock of Livent Corporation ("Livent"), par value $0.001 per share ("Livent Common Stock"), held by the reporting person as of January 4, 2024, into ordinary shares of Arcadium Lithium plc ("Arcadium"), par value $1.00 per share ("Arcadium Ordinary Shares"), in accordance with the terms of the Transaction Agreement, dated as of May 10, 2023, by and between Livent, Allkem Limited ("Allkem"), Lightning-A Merger Sub, Inc. and Arcadium, providing for a combination of Livent and Allkem in a merger of equals transaction (as amended, the "Transaction Agreement"). F1 · price: Represents the conversion of common stock of Livent Corporation ("Livent"), par value $0.001 per share ("Livent Common Stock"), held by the reporting person as of January 4, 2024, into ordinary shares of Arcadium Lithium plc ("Arcadium"), par value $1.00 per share ("Arcadium Ordinary Shares"), in accordance with the terms of the Transaction Agreement, dated as of May 10, 2023, by and between Livent, Allkem Limited ("Allkem"), Lightning-A Merger Sub, Inc. and Arcadium, providing for a combination of Livent and Allkem in a merger of equals transaction (as amended, the "Transaction Agreement"). Read SEC document |
| January 04, 2024 Filed Jan 8, 2024 21:05 UTC | Livent Corp. LTHM · Entity 95365 | Disposition to issuerCommon Stock | 32,875 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950103-24-000414 · dp204990_4-barry.xml · nonDerivative · entry 2 BARRY MICHAEL F · CIK 0001238141 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F2 · shares: Represents the cancellation and conversion of restricted stock units ("Livent RSUs") with respect to shares of Livent Common Stock, held by the reporting person as of January 4, 2024, into an amount of cash equal to (i) the number of shares of Livent Common Stock subject to such Livent RSUs immediately prior to the Effective Time of the merger (as defined in the Transaction Agreement), multiplied by (ii) the higher of (A) the first available closing price of the Merger Consideration (as defined in the Transaction Agreement) and (B) the closing price per share of Livent Common Stock as reported in the New York Stock Exchange, on the last trading day preceding the Closing Date of the merger (as defined in the Transaction Agreement). F2 · price: Represents the cancellation and conversion of restricted stock units ("Livent RSUs") with respect to shares of Livent Common Stock, held by the reporting person as of January 4, 2024, into an amount of cash equal to (i) the number of shares of Livent Common Stock subject to such Livent RSUs immediately prior to the Effective Time of the merger (as defined in the Transaction Agreement), multiplied by (ii) the higher of (A) the first available closing price of the Merger Consideration (as defined in the Transaction Agreement) and (B) the closing price per share of Livent Common Stock as reported in the New York Stock Exchange, on the last trading day preceding the Closing Date of the merger (as defined in the Transaction Agreement). Read SEC document |
| January 04, 2024 Filed Jan 8, 2024 21:05 UTC | Livent Corp. LTHM · Entity 95365 | Disposition to issuerCommon Stock | 34,475 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950103-24-000414 · dp204990_4-barry.xml · nonDerivative · entry 1 BARRY MICHAEL F · CIK 0001238141 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · shares: Represents the conversion of each share of common stock of the Livent Corporation ("Livent"), par value $0.001 per share ("Livent Common Stock"), held by the reporting person as of January 4, 2024, into the right to receive a number of validly issued, fully paid and non-assessable ordinary shares of Arcadium Lithium plc ("Arcadium"), par value $1.00 each ("Arcadium Shares") equal to the Merger Exchange Ratio (as defined in the Transaction Agreement, dated as of May 10, 2023, by and between Livent, Allkem Limited ("Allkem"), Lightning-A Merger Sub, Inc. and Arcadium, providing for a combination of Livent and Allkem in a merger of equals transaction (the "Transaction Agreement")). F1 · price: Represents the conversion of each share of common stock of the Livent Corporation ("Livent"), par value $0.001 per share ("Livent Common Stock"), held by the reporting person as of January 4, 2024, into the right to receive a number of validly issued, fully paid and non-assessable ordinary shares of Arcadium Lithium plc ("Arcadium"), par value $1.00 each ("Arcadium Shares") equal to the Merger Exchange Ratio (as defined in the Transaction Agreement, dated as of May 10, 2023, by and between Livent, Allkem Limited ("Allkem"), Lightning-A Merger Sub, Inc. and Arcadium, providing for a combination of Livent and Allkem in a merger of equals transaction (the "Transaction Agreement")). Read SEC document |
| June 01, 2023 Filed Jun 5, 2023 20:43 UTC | QUAKER CHEMICAL CORP KWR · Entity 4278 | GrantCommon Stock | 672 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-034371 · doc4.xml · nonDerivative · entry 1 BARRY MICHAEL F · CIK 0001238141 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 76,798 F1 · shares: Time-based restricted stock award granted to Quaker Houghton's non-executive directors as part of their 2023 compensation. Read SEC document |
| May 05, 2023 Filed May 8, 2023 20:32 UTC | QUAKER CHEMICAL CORP KWR · Entity 4278 | SaleCommon Stock | 400 | $206.68 | $82,670.12 |
DisclosureSEC source: 0001209191-23-027947 · doc4.xml · nonDerivative · entry 6 BARRY MICHAEL F · CIK 0001238141 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 76,126 F1 · kind: The sale of shares reported for this transaction was effected pursuant to a Rule 10b5-1 Plan entered into by reporting person on November 29, 2022. F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $205.92 to $206.90, inclusive. The reporting person undertakes to provide to Quaker Chemical Corporation, d/b/a "Quaker Houghton", any security holder of Quaker Houghton, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (7) to this Form 4. Read SEC document |
| May 05, 2023 Filed May 8, 2023 20:32 UTC | QUAKER CHEMICAL CORP KWR · Entity 4278 | SaleCommon Stock | 1,802 | $204.49 | $368,491.88 |
DisclosureSEC source: 0001209191-23-027947 · doc4.xml · nonDerivative · entry 5 BARRY MICHAEL F · CIK 0001238141 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 76,526 F1 · kind: The sale of shares reported for this transaction was effected pursuant to a Rule 10b5-1 Plan entered into by reporting person on November 29, 2022. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $204.02 to $205.00, inclusive. The reporting person undertakes to provide to Quaker Chemical Corporation, d/b/a "Quaker Houghton", any security holder of Quaker Houghton, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (6) to this Form 4. Read SEC document |
| May 05, 2023 Filed May 8, 2023 20:32 UTC | QUAKER CHEMICAL CORP KWR · Entity 4278 | SaleCommon Stock | 1,654 | $203.32 | $336,292.44 |
DisclosureSEC source: 0001209191-23-027947 · doc4.xml · nonDerivative · entry 4 BARRY MICHAEL F · CIK 0001238141 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 78,328 F1 · kind: The sale of shares reported for this transaction was effected pursuant to a Rule 10b5-1 Plan entered into by reporting person on November 29, 2022. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $203.00 to $203.93, inclusive. The reporting person undertakes to provide to Quaker Chemical Corporation, d/b/a "Quaker Houghton", any security holder of Quaker Houghton, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (5) to this Form 4. Read SEC document |
| May 05, 2023 Filed May 8, 2023 20:32 UTC | QUAKER CHEMICAL CORP KWR · Entity 4278 | SaleCommon Stock | 4,714 | $202.50 | $954,590.19 |
DisclosureSEC source: 0001209191-23-027947 · doc4.xml · nonDerivative · entry 3 BARRY MICHAEL F · CIK 0001238141 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 79,982 F1 · kind: The sale of shares reported for this transaction was effected pursuant to a Rule 10b5-1 Plan entered into by reporting person on November 29, 2022. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $202.00 to $202.98 Corporation, d/b/a "Quaker Houghton", any security holder of Quaker Houghton, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (4) to this Form 4. Read SEC document |
| May 05, 2023 Filed May 8, 2023 20:32 UTC | QUAKER CHEMICAL CORP KWR · Entity 4278 | SaleCommon Stock | 3,596 | $201.41 | $724,281.51 |
DisclosureSEC source: 0001209191-23-027947 · doc4.xml · nonDerivative · entry 2 BARRY MICHAEL F · CIK 0001238141 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 84,696 F1 · kind: The sale of shares reported for this transaction was effected pursuant to a Rule 10b5-1 Plan entered into by reporting person on November 29, 2022. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $201.00 to $201.97, inclusive. The reporting person undertakes to provide to Quaker Chemical Corporation, d/b/a "Quaker Houghton", any security holder of Quaker Houghton, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form 4. Read SEC document |
| May 05, 2023 Filed May 8, 2023 20:32 UTC | QUAKER CHEMICAL CORP KWR · Entity 4278 | SaleCommon Stock | 1,834 | $200.64 | $367,971.38 |
DisclosureSEC source: 0001209191-23-027947 · doc4.xml · nonDerivative · entry 1 BARRY MICHAEL F · CIK 0001238141 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 88,292 F1 · kind: The sale of shares reported for this transaction was effected pursuant to a Rule 10b5-1 Plan entered into by reporting person on November 29, 2022. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $200.00 to $200.96, inclusive. The reporting person undertakes to provide to Quaker Chemical Corporation, d/b/a "Quaker Houghton", any security holder of Quaker Houghton, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. Read SEC document |
| May 01, 2023 Filed May 3, 2023 20:10 UTC | Livent Corp. LTHM · Entity 95365 | GrantCommon Stock | 5,027 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-010070 · form4.xml · nonDerivative · entry 1 BARRY MICHAEL F · CIK 0001238141 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 67,350 F1 · shares: The shares were issued to the reporting person pursuant to the Livent Corporation Compensation Policy for Non-Employee Directors as an annual equity grant. Read SEC document |
| April 14, 2023 Filed Apr 14, 2023 20:29 UTC | QUAKER CHEMICAL CORP KWR · Entity 4278 | SaleCommon Stock | 200 | $200.00 | $40,000.00 |
DisclosureSEC source: 0001209191-23-024318 · doc4.xml · nonDerivative · entry 2 BARRY MICHAEL F · CIK 0001238141 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 90,126 F1 · kind: The sale of shares reported for this transaction was effected pursuant to a Rule 10b5-1 Plan entered into by reporting person on November 29, 2022. Read SEC document |
| April 12, 2023 Filed Apr 14, 2023 20:29 UTC | QUAKER CHEMICAL CORP KWR · Entity 4278 | SaleCommon Stock | 100 | $200.21 | $20,021.00 |
DisclosureSEC source: 0001209191-23-024318 · doc4.xml · nonDerivative · entry 1 BARRY MICHAEL F · CIK 0001238141 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 90,326 F1 · kind: The sale of shares reported for this transaction was effected pursuant to a Rule 10b5-1 Plan entered into by reporting person on November 29, 2022. Read SEC document |
| March 30, 2023 Filed Apr 3, 2023 20:30 UTC | QUAKER CHEMICAL CORP KWR · Entity 4278 | Tax withholdingCommon Stock | 2,392 | $193.35 | $462,493.20 |
DisclosureSEC source: 0001209191-23-022216 · doc4.xml · nonDerivative · entry 1 BARRY MICHAEL F · CIK 0001238141 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 90,426 F1 · shares: Shares surrendered by reporting person to satisfy withholding tax obligation upon vesting of restricted stock granted on March 30, 2020 under the Company's 2016 Long-Term Performance Incentive Plan. Read SEC document |
| March 06, 2023 Filed Mar 7, 2023 21:39 UTC | QUAKER CHEMICAL CORP KWR · Entity 4278 | SaleCommon Stock | 300 | $200.03 | $60,009.00 |
DisclosureSEC source: 0001209191-23-016780 · doc4.xml · nonDerivative · entry 2 BARRY MICHAEL F · CIK 0001238141 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,818 F1 · kind: The sale of shares reported for this transaction was effected pursuant to a Rule 10b5-1 Plan entered into by reporting person on November 29, 2022. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $200.00 to $200.05, inclusive. The reporting person undertakes to provide to Quaker Chemical Corporation, d/b/a "Quaker Houghton", any security holder of Quaker Houghton, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form 4. Read SEC document |
| March 03, 2023 Filed Mar 7, 2023 21:39 UTC | QUAKER CHEMICAL CORP KWR · Entity 4278 | SaleCommon Stock | 400 | $200.02 | $80,009.00 |
DisclosureSEC source: 0001209191-23-016780 · doc4.xml · nonDerivative · entry 1 BARRY MICHAEL F · CIK 0001238141 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,118 F1 · kind: The sale of shares reported for this transaction was effected pursuant to a Rule 10b5-1 Plan entered into by reporting person on November 29, 2022. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $200.00 to $200.09, inclusive. The reporting person undertakes to provide to Quaker Chemical Corporation, d/b/a "Quaker Houghton", any security holder of Quaker Houghton, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. Read SEC document |
| February 02, 2023 Filed Feb 3, 2023 21:23 UTC | QUAKER CHEMICAL CORP KWR · Entity 4278 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 16,426 | $0.00 Strike: $136.64 | $0.00 |
DisclosureSEC source: 0001209191-23-006849 · doc4.xml · derivative · entry 19 BARRY MICHAEL F · CIK 0001238141 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,212 Underlying: Common Stock · 16,426 shares Expires 2027-03-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F13 · derivative.exercise_date: The options for this grant vest in three annual installments: 8,213 shares on March 30, 2021; 8,213 shares on March 30, 2022; and 8,212 shares on March 30, 2023. Read SEC document |
| February 02, 2023 Filed Feb 3, 2023 21:23 UTC | QUAKER CHEMICAL CORP KWR · Entity 4278 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 14,128 | $0.00 Strike: $154.92 | $0.00 |
DisclosureSEC source: 0001209191-23-006849 · doc4.xml · derivative · entry 18 BARRY MICHAEL F · CIK 0001238141 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 14,128 shares Expires 2026-02-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F12 · derivative.exercise_date: The options for this grant vested in three annual installments: 7,065 shares on February 25, 2020; 7,064 shares on February 25, 2021; and 7,064 shares on February 25, 2022. Read SEC document |
| February 02, 2023 Filed Feb 3, 2023 21:23 UTC | QUAKER CHEMICAL CORP KWR · Entity 4278 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 6,750 | $0.00 Strike: $151.75 | $0.00 |
DisclosureSEC source: 0001209191-23-006849 · doc4.xml · derivative · entry 17 BARRY MICHAEL F · CIK 0001238141 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,750 shares Expires 2025-02-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F11 · derivative.exercise_date: The options for this grant vested in three annual installments: 6,751 shares on February 26, 2019; 6,750 shares on February 26, 2020; and 6,750 shares on February 26, 2021. Read SEC document |
| February 02, 2023 Filed Feb 3, 2023 21:23 UTC | QUAKER CHEMICAL CORP KWR · Entity 4278 | Tax withholdingCommon Stock | 12,847 | $215.58 | $2,769,556.26 |
DisclosureSEC source: 0001209191-23-006849 · doc4.xml · nonDerivative · entry 16 BARRY MICHAEL F · CIK 0001238141 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,518 Read SEC document |
| February 02, 2023 Filed Feb 3, 2023 21:23 UTC | QUAKER CHEMICAL CORP KWR · Entity 4278 | Exercise / conversionCommon Stock | 16,426 | $136.64 | $2,244,448.64 |
DisclosureSEC source: 0001209191-23-006849 · doc4.xml · nonDerivative · entry 15 BARRY MICHAEL F · CIK 0001238141 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,365 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 02, 2023 Filed Feb 3, 2023 21:23 UTC | QUAKER CHEMICAL CORP KWR · Entity 4278 | Tax withholdingCommon Stock | 11,838 | $215.58 | $2,552,036.04 |
DisclosureSEC source: 0001209191-23-006849 · doc4.xml · nonDerivative · entry 14 BARRY MICHAEL F · CIK 0001238141 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,939 Read SEC document |
| February 02, 2023 Filed Feb 3, 2023 21:23 UTC | QUAKER CHEMICAL CORP KWR · Entity 4278 | Exercise / conversionCommon Stock | 14,128 | $154.92 | $2,188,709.76 |
DisclosureSEC source: 0001209191-23-006849 · doc4.xml · nonDerivative · entry 13 BARRY MICHAEL F · CIK 0001238141 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 101,777 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 02, 2023 Filed Feb 3, 2023 21:23 UTC | QUAKER CHEMICAL CORP KWR · Entity 4278 | Tax withholdingCommon Stock | 5,635 | $215.58 | $1,214,793.30 |
DisclosureSEC source: 0001209191-23-006849 · doc4.xml · nonDerivative · entry 12 BARRY MICHAEL F · CIK 0001238141 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,649 Read SEC document |
| February 02, 2023 Filed Feb 3, 2023 21:23 UTC | QUAKER CHEMICAL CORP KWR · Entity 4278 | Exercise / conversionCommon Stock | 6,750 | $151.75 | $1,024,312.50 |
DisclosureSEC source: 0001209191-23-006849 · doc4.xml · nonDerivative · entry 11 BARRY MICHAEL F · CIK 0001238141 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,284 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 01, 2023 Filed Feb 3, 2023 21:23 UTC | QUAKER CHEMICAL CORP KWR · Entity 4278 | SaleCommon Stock | 352 | $205.40 | $72,300.80 |
DisclosureSEC source: 0001209191-23-006849 · doc4.xml · nonDerivative · entry 10 BARRY MICHAEL F · CIK 0001238141 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,534 F1 · kind: The sale of shares reported for this transaction was effected pursuant to a Rule 10b5-1 Plan entered into by reporting person on November 29, 2022. F10 · shares: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $205.13 to $205.88, inclusive. The reporting person undertakes to provide to Quaker Chemical Corporation, d/b/a "Quaker Houghton", any security holder of Quaker Houghton, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (10) to this Form 4. F10 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $205.13 to $205.88, inclusive. The reporting person undertakes to provide to Quaker Chemical Corporation, d/b/a "Quaker Houghton", any security holder of Quaker Houghton, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (10) to this Form 4. Read SEC document |
| February 01, 2023 Filed Feb 3, 2023 21:23 UTC | QUAKER CHEMICAL CORP KWR · Entity 4278 | SaleCommon Stock | 494 | $204.58 | $101,064.55 |
DisclosureSEC source: 0001209191-23-006849 · doc4.xml · nonDerivative · entry 9 BARRY MICHAEL F · CIK 0001238141 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,886 F1 · kind: The sale of shares reported for this transaction was effected pursuant to a Rule 10b5-1 Plan entered into by reporting person on November 29, 2022. F9 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $204.07 to $205.02, inclusive. The reporting person undertakes to provide to Quaker Chemical Corporation, d/b/a "Quaker Houghton", any security holder of Quaker Houghton, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (9) to this Form 4. Read SEC document |
| February 01, 2023 Filed Feb 3, 2023 21:23 UTC | QUAKER CHEMICAL CORP KWR · Entity 4278 | SaleCommon Stock | 3,091 | $203.30 | $628,405.55 |
DisclosureSEC source: 0001209191-23-006849 · doc4.xml · nonDerivative · entry 8 BARRY MICHAEL F · CIK 0001238141 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,380 F1 · kind: The sale of shares reported for this transaction was effected pursuant to a Rule 10b5-1 Plan entered into by reporting person on November 29, 2022. F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $203.03 to $203.98, inclusive. The reporting person undertakes to provide to Quaker Chemical Corporation, d/b/a "Quaker Houghton", any security holder of Quaker Houghton, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (8) to this Form 4. Read SEC document |
| February 01, 2023 Filed Feb 3, 2023 21:23 UTC | QUAKER CHEMICAL CORP KWR · Entity 4278 | SaleCommon Stock | 2,301 | $202.62 | $466,224.25 |
DisclosureSEC source: 0001209191-23-006849 · doc4.xml · nonDerivative · entry 7 BARRY MICHAEL F · CIK 0001238141 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,471 F1 · kind: The sale of shares reported for this transaction was effected pursuant to a Rule 10b5-1 Plan entered into by reporting person on November 29, 2022. F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $202.03 to $203.02, inclusive. The reporting person undertakes to provide to Quaker Chemical Corporation, d/b/a "Quaker Houghton", any security holder of Quaker Houghton, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (7) to this Form 4. Read SEC document |
| February 01, 2023 Filed Feb 3, 2023 21:23 UTC | QUAKER CHEMICAL CORP KWR · Entity 4278 | SaleCommon Stock | 200 | $200.91 | $40,182.00 |
DisclosureSEC source: 0001209191-23-006849 · doc4.xml · nonDerivative · entry 6 BARRY MICHAEL F · CIK 0001238141 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,772 F1 · kind: The sale of shares reported for this transaction was effected pursuant to a Rule 10b5-1 Plan entered into by reporting person on November 29, 2022. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $200.79 to $201.03, inclusive. The reporting person undertakes to provide to Quaker Chemical Corporation, d/b/a "Quaker Houghton", any security holder of Quaker Houghton, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (6) to this Form 4. Read SEC document |
| February 01, 2023 Filed Feb 3, 2023 21:23 UTC | QUAKER CHEMICAL CORP KWR · Entity 4278 | SaleCommon Stock | 100 | $199.50 | $19,950.00 |
DisclosureSEC source: 0001209191-23-006849 · doc4.xml · nonDerivative · entry 5 BARRY MICHAEL F · CIK 0001238141 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,972 F1 · kind: The sale of shares reported for this transaction was effected pursuant to a Rule 10b5-1 Plan entered into by reporting person on November 29, 2022. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.